EUVIMEDOpdag EUVIMED
Klinische Studie

Efficacy and safety of the Rezum system for the treatment of catheter‐dependent urinary retention: Three‐year real‐world outcomes in a multimorbid, multiethnic population

Mustufa Babar iD, Zaki Masoud, Kevin Labagnara iD, Justin Loloi, Rahman Sayed, Sandeep Singh, Kevin Tang iD, Umar Syed, Michael Ciatto

LUTS: Lower Urinary Tract Symptoms · 2023

DOI: 10.1111/luts.12482 ↗

At a glance

Klinische Studie in LUTS: Lower Urinary Tract Symptoms, 2023. Written by Mustufa Babar and 8 co-authors. Institution: Albert Einstein College of Medicine, Bronx, New York, USA. Major MEDLINE topics: Lower Urinary Tract Symptoms, Prostatic Hyperplasia, Urinary Retention, Urinary Tract Infections. Cited 5 times so far (Crossref); 19 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objectives

To evaluate the long‐term real‐world efficacy and safety of Rezum for the treatment of catheter‐dependent urinary retention in a multimorbid, multiethnic population.

Methods

A single‐office, retrospective study was conducted on patients treated with Rezum between 2017 and 2019. Patients were included if they had catheter‐dependent urinary retention prior to treatment and at least one follow‐up within 36 months postoperatively. Patient demographics, procedural characteristics, adverse events (AEs), and outcome measures, including benign prostate hyperplasia (BPH) medication usage and postvoid residual (PVR), were collected at 3, 6, 12, and/or 36 months postoperatively. Regret was assessed at 36 months using the 5‐item Decisional Regret Scale (DRS).

Results

A total of 27 patients met the inclusion criteria, with the majority being Asian (29.6%), followed by non‐Hispanic Black (26.0%) and Hispanic (22.2%). Most patients (77.8%) had at least one comorbidity. Trial of void (TOV) was attempted at a median of 8 days (7, 13). Fourteen patients (51.9%) failed their initial TOV. Median time until catheter independence was 13.5 days (8.5, 28.8). Common AEs included urinary retention (51.9%), urinary tract infections (UTIs) (25.9%), and dysuria (25.9%). All cases of UTIs (7/7) and most cases of dysuria (6/7) occurred in patients who failed their initial TOV. At 36 months, there was a significant median percentage change in PVR (−100.0% [−100.0, −36.7], p = .049), and 40.4% of patients discontinued their BPH medications ( p = .001). Of the 11 patients who filled out the DRS, 10 (90.9%) agreed/strongly agreed that they made the right decision. By 36 months, 4 patients (14.8%) underwent reoperation and 24 (88.9%) remained catheter‐independent.

Conclusions

At long‐term follow‐up, Rezum effectively treated catheter‐dependent urinary retention with minimal decisional regret. In patients with urinary retention, urologists should consider delaying TOV until 2 weeks postoperatively to maximize the likelihood of a successful TOV and minimize the risk of AEs.

Subjects

MeSH terms (MEDLINE)

Lower Urinary Tract SymptomsProstatic HyperplasiaUrinary RetentionUrinary Tract InfectionsHumansMaleDysuriaRetrospective StudiesTreatment Outcome

Author keywords

benign prostatic hyperplasialower urinary tract symptomsminimally invasive surgical therapyurinary catheterurinary retention

Authors and institutions

  • Albert Einstein College of Medicine, Bronx, New York, USA.
  • DSS Urology, Queens Village, New York, USA.
  • Department of Urology, Montefiore Medical Center, Bronx, New York, USA.

ORCID profiles: Mustufa Babar, Kevin Labagnara, Kevin Tang

Cite

APA

Babar, M., Masoud, Z., Labagnara, K., Loloi, J., Sayed, R., Singh, S., Tang, K., Syed, U., & Ciatto, M. (2023). Efficacy and safety of the Rezum system for the treatment of catheter‐dependent urinary retention: Three‐year real‐world outcomes in a multimorbid, multiethnic population. LUTS: Lower Urinary Tract Symptoms. https://doi.org/10.1111/luts.12482

Vancouver

Babar M, Masoud Z, Labagnara K, Loloi J, Sayed R, Singh S, et al. Efficacy and safety of the Rezum system for the treatment of catheter‐dependent urinary retention: Three‐year real‐world outcomes in a multimorbid, multiethnic population. LUTS: Lower Urinary Tract Symptoms. 2023. doi:10.1111/luts.12482

BibTeX
@article{Babar2023,
  author = {Babar, Mustufa and Masoud, Zaki and Labagnara, Kevin and Loloi, Justin and Sayed, Rahman and Singh, Sandeep and Tang, Kevin and Syed, Umar and Ciatto, Michael},
  title = {Efficacy and safety of the Rezum system for the treatment of catheter‐dependent urinary retention: Three‐year real‐world outcomes in a multimorbid, multiethnic population},
  journal = {LUTS: Lower Urinary Tract Symptoms},
  year = {2023},
  doi = {10.1111/luts.12482}
}
Start for free →